• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Auxilium Pharmaceuticals Inc

+ Add to Watchlist

AUXL:US

18.5900 USD 0.0400 0.21%

As of 20:10:00 ET on 08/27/2014.

Snapshot for Auxilium Pharmaceuticals Inc (AUXL)

Open: 18.7400 Day's Range: 18.4400 - 19.0500 Volume: 521,428
Previous Close: 18.6300 52wk Range: 16.3600 - 32.8900 1-Yr Rtn: +3.34%

Stock Chart for AUXL

No chart data available.
  • AUXL:US 18.5900
  • 1D
  • 1M
  • 1Y
18.6300
Interactive AUXL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AUXL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.7744
Est. EPS (USD) (12/2014) -0.4040
Est. PEG Ratio -
Market Cap (M USD) 936.10
Shares Outstanding (M) 50.35
30 Day Average Volume 934,528
Price/Book (mrq) 5.2095
Price/Sale (ttm) 2.2759
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AUXL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AUXL

Auxilium Pharmaceuticals Inc. is a biopharmaceutical company . The Company develops and markets therapeutics to urologists, endocrinologists, orthopedists and select primary care physicians.

Adrian AdamsPresident/CEOAndrew SaikChief Financial Officer
Andrew I KovenCAO/Secretary/General CounselElizabeth Varki JobesChief Compliance Officer
More Company Profile & Key Executives for AUXL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil